Does the maternal microbiome shape infant immune system development?

How does the maternal microbiome influence infant immune development?

The maternal microbiome shapes infant immunity through at least three distinct routes: direct microbial transfer during birth, transfer of immune molecules through breast milk, and metabolic signals that program the infant's immune system before birth. A systematic review of 74 studies found that cesarean delivery and antibiotic use during pregnancy increased allergy risk, while breastfeeding and probiotics were protective [1]. This is because vaginal birth exposes infants to maternal vaginal and gut microbes, while C-section babies initially acquire skin-like bacteria instead [11].

One of the most concrete mechanisms involves maternal antibodies. A 2022 study in mice showed that gut microbiome-induced IgG antibodies are transferred from mother to pup through milk via the neonatal Fc receptor [3]. These antibodies directly inhibited colonization by the pathogen Citrobacter rodentium in the pup's gut. When the researchers created mice completely lacking IgG, the pups were more susceptible to infection and showed lasting changes in their gut microbiome and immune cells that persisted into adulthood [3].

Another key pathway is through bacterial metabolites like short-chain fatty acids (SCFAs). A 2023 study found that maternal γδ T cells (a type of immune cell) shape the offspring's lung immunity by influencing the infant's gut microbiome and SCFA levels [12]. Pups born to mothers lacking γδ T cells had lower levels of SCFAs like pentanoate and hexanoate, and developed excessive type-2 inflammation in the lungs after birth and during infection. Supplementing the pups with SCFAs reversed this effect, suppressing the harmful inflammation [12].

Where do the studies agree?

There is strong consensus that the maternal gut microbiome during pregnancy has a significant impact on infant immune development and later disease risk. Multiple reviews and original studies agree that factors disrupting the maternal microbiome—such as antibiotics, poor diet, stress, and C-section delivery—are associated with increased allergy, asthma, and infection risk in offspring [1][2][7]. For example, a 2021 review proposed that maternal carriage of Prevotella copri during pregnancy may reduce allergy risk in children by producing succinate, which promotes dendritic cell development in the fetal bone marrow [7].

There is also agreement that the maternal microbiome influences the infant's gut microbiome composition. A mouse study using non-absorbable antibiotics to disrupt the maternal gut microbiota found that the offspring's gut microbiome closely mirrored the mother's altered profile, demonstrating vertical transmission [10]. Similarly, a 2023 study showed that maternal diet (low-fiber vs. high-fiber) changed the composition of maternal milk microbes and the infant gut microbiome, which in turn affected immune cell development in the lungs [4].

The role of breastfeeding as a conduit for maternal microbial and immune factors is also well-supported. A 2021 study found that Lactobacillus reuteri, enriched in the milk of immunodeficient mouse dams, could induce IgA production in nursing pups [9]. And a 2021 study on RSV infection showed that maternal supplementation with Lactobacillus johnsonii led to reduced lung inflammation in offspring, with effects mediated through both prenatal and postnatal exposure [8].

Where do the studies disagree or show nuance?

A major point of disagreement concerns the role of the maternal vaginal microbiome. While it has long been assumed that vaginal microbes are a primary source of the infant gut microbiome, a large 2023 prospective cohort study of 621 Canadian mother-infant pairs found that maternal vaginal microbiome composition at delivery did not affect infant stool microbiome composition at 10 days or 3 months of life [5]. The study concluded that differences seen between C-section and vaginal birth infants were not explained by vaginal microbes, but rather by other factors like intrapartum antibiotics [5]. This directly challenges the rationale for practices like vaginal seeding, which aim to restore vaginal microbes to C-section babies [6].

Another area of nuance is the timing and specificity of maternal influence. While some studies emphasize in utero programming (e.g., maternal metabolites affecting fetal immune development [7][8]), others highlight that the most critical transfer occurs during and after birth through milk and skin contact [6][9]. A 2023 review noted that only a few studies have directly examined the interactions between the gut microbiome and immune system during pregnancy, and the field is still nascent [2].

Finally, the functional consequences of maternal microbiome-induced immune changes are not always clear. For example, a 2021 study found that maternal microbiota-induced neonatal IgA in mice did not cross-react with common enteric pathogens, leaving its protective role uncertain [9]. Similarly, while many studies show associations between maternal microbiome disruptions and offspring allergy or infection risk, translating these findings into effective interventions remains a challenge [1][7].

Sources used in this answer

Related research questions